MIF
UTHR icon

Mediolanum International Funds’s United Therapeutics UTHR Stock Holding History

Mediolanum International Funds’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
390
-569
-59% -$320K ﹤0.01% 446
2026
Q1 		$564K Sell
959
-5,501
-85% -$2.74M 0.01% 414
2025
Q4 		$3.21M Sell
6,460
-7,672
-54% -$3.57M 0.03% 313
2025
Q3 		$6M Sell
14,132
-4,275
-23% -$1.44M 0.06% 245
2025
Q2 		$5.23M Buy
18,407
+3,150
+21% +$941K 0.06% 247
2025
Q1 		$4.68M Buy
15,257
+10,036
+192% +$3.44M 0.06% 254
2024
Q4 		$1.86M Buy
5,221
+417
+9% +$153K 0.02% 327
2024
Q3 		$1.72M Buy
4,804
+312
+7% +$105K 0.02% 344
2024
Q2 		$1.33M Sell
4,492
-683
-13% -$181K 0.02% 327
2024
Q1 		$1.26M Buy
+5,175
New +$1.17M 0.02% 331

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Mediolanum International Funds's UTHR Position: Q2 2026 in Review

Mediolanum International Funds reduced its United Therapeutics (UTHR) stake by 59% in Q2 2026, selling an estimated $320K and leaving 390 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

Mediolanum International Funds first reported a position in UTHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $6M in Q3 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Mediolanum International Funds held 390 shares of United Therapeutics worth $213K as of Q2 2026.
  • Mediolanum International Funds sold 569 United Therapeutics shares in Q2 2026, an estimated $320K.
  • United Therapeutics made up ﹤0.01% of Mediolanum International Funds's portfolio in Q2 2026, its #446 holding.
  • Mediolanum International Funds first reported a position in United Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Mediolanum International Funds's United Therapeutics position peaked at $6M in Q3 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.